viable proposition, a more internationally orientated and larger input of advertisements must be aimed for. Given additional revenue from this source, a more frequent publication schedule can be aimed for. Although a quarterly frequency of publication for the third edition is being maintained, a larger issue size will be promoted, so that the time between acceptance of a paper and its publication will be kept to a reasonable minimum. It is important to balance each issue between clinical and industrial interests, and not to place undue emphasis on instrument evaluations; the increased issue size will help in this respect.
Multidisciplinary approaches
It has often been stated in these columns that the subject of automated chemistry, be it for the industrial or for the clinical market, requires a multidisciplinary approach. Chemistry must be interfaced with electronics, mechanical engineering, computer techniques and software developments, amongst other aspects. In addition, a proper protocol must be established in order to obtain data which can be correlated, both within a laboratory, and between laboratories.
It is promising that over the last year in the UK two significant developments have been made which will promote the concepts of a multidisciplinary education, and also will es- Analysis, will form a major area of activity for this group. Again, strong ties between senior industrial researchers will be promoted, as well as co-operation from academic colleagues in other departments to work on multidisciplinary projects, particularly those involving microelectronics. These activities will serve to augment the already established programme of research in automated analytical chemistry pioneered by Prof. Betteridge and his group.
Both groups should be encouraged and I am sure from their beginnings that they will shortly have a valuable input in the sphere of automated analytical chemistry.
Highlights of 1980
It is almost impossible to cover all the developments made over the last year in a short summary, and any attempt to do so would not be rewarding. However, a few aspects appear to me to be particularly significant. After what can only be considered a very lor/g gestation period, the solid phase, or layer chemistry, developed by Eastman Kodak has been launched on the clinical market.
In addition to the reflectance spectroscopy used for glucose measurements etc., an electrolyte version has also been developed. There has been a similar advancement from the Ames group in their Seralyzer developments. Both of these approaches will obviously benefit from the ground work carried out by the DuPont company when establishing a market for their ACA equipment. All of these approaches take a great deal of the responsibility for method developments and research away from clinical chemists and place considerable responsibility upon the instrument companies. The problems inherent in this approach have been discussed 
